European Commission committee reiterates that mercury sphygmomanometers can be replaced
This article was originally published in RAJ Devices
Executive Summary
The European Commission's Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) has reiterated the message that there is no evidence of any adverse effects on patients' health from replacement of mercury-containing sphygmomanometers with mercury-free alternatives1.
You may also be interested in...
Second EU MDR Notified Body Designated In France
Four years after the designation of the first notified body in France under the Medical Device Regulation, AFNOR Certification has been named too.
EU Regulatory Experts Support Notified Bodies, But Argue For Greater Consistency
Notified bodies have been a pivotal part of the EU medtech regulatory system since it was first launched in the 1990s. Where might they fit within a new medtech regulatory governance structure? Panelists on a recent vodcast grappled with the question.
First Public Discussion On How EU Medtech Regulatory Governance Structure May Evolve
Does the EU need a medtech agency for the first time in its history? Nothing can or should be decided too quickly but five high-profile experts broadly agreed that change is now critical.